Ali H Aligiraigri

7PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursTumour immunologyPredictive and prognostic markersHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 04, 2026
Timing Matters: Optimizing Oncology Involvement in Pediatric Neuro-Oncology Pathways in Saudi Arabia.

|May 13, 2026
Differential Expression and Target Gene Analysis of PBMC-Derived microRNAs as Prognostic Biomarkers in Acute Lymphoblastic Leukemia.

|May 01, 2025
Optimizing Outcomes in Childhood Mature B-cell Non-Hodgkin Lymphoma: Insights Into Staging, Risk Stratification, and Response Evaluation.

Ali H Algiraigri

|Mar 21, 2025
Intrathecal chemotherapy neurotoxicity: unveiling the challenges of diagnosis, management, and prevention.

Ali H Algiraigri, Wasil Jastaniah

|Oct 26, 2024
T-Cell Immunoglobulin and Mucin Domain 3 (TIM-3) Gene Expression as a Negative Biomarker of B-Cell Acute Lymphoblastic Leukemia.

Fatemah S Basingab, Manar Bashanfer, Aisha A Alrofaidi

|Mar 09, 2021
Molecular differential analysis of uterine leiomyomas and leiomyosarcomas through weighted gene network and pathway tracing approaches.

Nora Naif Sahly, Babajan Banaganapalli, Ahmed N Sahly

Pageof 2

Frequent Collaborators

2 joint publications

Fatemah S Basingab

2 joint publications

Ahmed S Barefah

2 joint publications

Rawan Hammad

2 joint publications

Jehan S Alrahimi